Last reviewed · How we verify

NCT03721393: COST3

Data Collection - Of Syncope Tilt Table Testing Study

Completed Last updated 2 August 2023
What this trial tests

trial testing Wearable heart monitor in Orthostatic Hypotension in 50 participants. Completed in 8 May 2023.

Timeline
4 October 2019
Primary endpoint
8 May 2023
8 May 2023

Quick facts

Lead sponsorBoston Scientific Corporation
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date4 October 2019
Primary completion8 May 2023
Estimated completion8 May 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Boston Scientific Corporation — full company profile →

Who can join

18 and older, any sex, with Orthostatic Hypotension or Reflex Syncope. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To characterize the impact of orthostatic hypotension (OH) and reflex syncope on signals measured using a wearable cardiac monitor prototype device. To evaluate the relationship of signals measured from the wearable cardiac monitor prototype device with reported symptom severity of orthostatic intolerance per standard data collection, analysis, and questionnaires.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Orthostatic Hypotension

Currently open trials in the same condition.

Other Boston Scientific Corporation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03721393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing